Advanced in Gamma Knife Radiosurgery

Dr. Michael A. Vogelbaum

Neurosurgery
H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc
12902 Usf Magnolia Dr, 
Tampa, FL 
Accepting New Patients
Offers Telehealth
Advanced in Gamma Knife Radiosurgery
H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc
12902 Usf Magnolia Dr, 
Tampa, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Vogelbaum is a Neurosurgery provider in Tampa, Florida. Dr. Vogelbaum is rated as an Advanced provider by MediFind in Gamma Knife Radiosurgery. His top areas of expertise are Glioma, Brain Tumor, Gliomatosis Cerebri, Awake Craniotomy, and Gamma Knife Radiosurgery. Dr. Vogelbaum is currently accepting new patients.

His clinical research consists of co-authoring 242 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Gamma Knife Radiosurgery.

Specialties
Neurosurgery
Licenses
Neurological Surgery in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Sunshine Health
  • EPO
  • HMO
View 2 Less Insurance Carriers -

Locations

H LEE MOFFITT CANCER CTR AND RES INST LIFE TIME CANCER SCRN CTR INC
12902 Usf Magnolia Dr, Tampa, FL 33612

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on the Tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Stereotactic Radiotherapy in Recurrent Glioblastoma
A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on the Tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Stereotactic Radiotherapy in Recurrent Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: September 25, 2025
Intervention Type: Procedure, Biological, Radiation
Study Drugs: Atezolizumab, Tocilizumab
Study Phase: Phase 2
Pre-operative Hypofractionated Stereotactic Radiosurgery for Resectable Brain Metastases
Pre-operative Hypofractionated Stereotactic Radiosurgery for Resectable Brain Metastases
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Radiation
Study Phase: Phase 2
A Pilot Study of Intratumorally and Intraparenchymally Administered OS2966 Using Convection-enhanced Delivery in Patients With Recurrent/Progressive High-grade Glioma Undergoing a Clinically-indicated Surgical Resection
A Pilot Study of Intratumorally and Intraparenchymally Administered OS2966 Using Convection-enhanced Delivery in Patients With Recurrent/Progressive High-grade Glioma Undergoing a Clinically-indicated Surgical Resection
Enrollment Status: Terminated
Publish Date: August 18, 2023
Intervention Type: Drug
Study Drugs: OS2966, Gadoteridol
Study Phase: Phase 1
A Study of Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery (CED) in Patients With Suspected Recurrent/Progressive World Health Organization (WHO) Grade III or IV (High Grade) Glioma Undergoing Stereotactic Biopsy
A Study of Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery (CED) in Patients With Suspected Recurrent/Progressive World Health Organization (WHO) Grade III or IV (High Grade) Glioma Undergoing Stereotactic Biopsy
Enrollment Status: Terminated
Publish Date: May 25, 2023
Intervention Type: Drug
Study Drug: Topotecan
Study Phase: Early Phase 1
An Open-Label Non-Randomized, Multi-Center Phase-2 Study of Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
An Open-Label Non-Randomized, Multi-Center Phase-2 Study of Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
Enrollment Status: Completed
Publish Date: October 24, 2022
Intervention Type: Drug
Study Phase: Phase 2
Clinical Study of the Utility of a Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas
Clinical Study of the Utility of a Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas
Enrollment Status: Completed
Publish Date: May 31, 2022
Intervention Type: Drug, Device
A Phase II, Multi-center, Open-label Study of a Conditionally Replicative Adenovirus (DNX-2401) With Pembrolizumab (KEYTRUDA®) for Recurrent Glioblastoma or Gliosarcoma (CAPTIVE/KEYNOTE-192)
A Phase II, Multi-center, Open-label Study of a Conditionally Replicative Adenovirus (DNX-2401) With Pembrolizumab (KEYTRUDA®) for Recurrent Glioblastoma or Gliosarcoma (CAPTIVE/KEYNOTE-192)
Enrollment Status: Completed
Publish Date: July 15, 2021
Intervention Type: Biological
Study Drugs: DNX-2401 Adeno-Associated Oncolytic Virus Delta-24 Vaccine, Pembrolizumab
Study Phase: Phase 2
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
Enrollment Status: Terminated
Publish Date: February 07, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
Pilot Trial of Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery (CED) in Patients With Suspected Recurrent/Progressive World Health Organization (WHO) Grade III or IV (High Grade) Glioma Undergoing Stereotactic Biopsy (IND 117,240)
Pilot Trial of Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery (CED) in Patients With Suspected Recurrent/Progressive World Health Organization (WHO) Grade III or IV (High Grade) Glioma Undergoing Stereotactic Biopsy (IND 117,240)
Enrollment Status: Withdrawn
Publish Date: March 01, 2019
Intervention Type: Device, Drug, Diagnostic test
Study Phase: Early Phase 1
View 8 Less Clinical Trials

242 Total Publications

Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium.
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium.
Journal: Neuro-oncology
Published: August 30, 2025
Similar Doctors
Experienced in Gamma Knife Radiosurgery
Dr. Arnold B. Etame
Neurosurgery
Experienced in Gamma Knife Radiosurgery
Dr. Arnold B. Etame
Neurosurgery

H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc

12902 Usf Magnolia Dr, 
Tampa, FL 
 (0.1 miles away)
888-860-2778
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Arnold Etame is a Neurosurgery provider in Tampa, Florida. Dr. Etame is rated as a Distinguished provider by MediFind in Gamma Knife Radiosurgery. His top areas of expertise are Brain Tumor, Glioblastoma, Astrocytoma, Awake Craniotomy, and Gamma Knife Radiosurgery. Dr. Etame is currently accepting new patients.

Experienced in Gamma Knife Radiosurgery
Dr. Peter L. Mayer
Neurosurgery
Experienced in Gamma Knife Radiosurgery
Dr. Peter L. Mayer
Neurosurgery

Neurosurgery And Spine Specialists

5831 Bee Ridge Rd, Suite 100, 
Sarasota, FL 
 (52.8 miles away)
941-308-5700
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Peter Mayer is a Neurosurgery provider in Sarasota, Florida. Dr. Mayer is rated as a Distinguished provider by MediFind in Gamma Knife Radiosurgery. His top areas of expertise are Delirium, Cervical Myelopathy, Apoplexy, Bone Graft, and Vertebroplasty. Dr. Mayer is currently accepting new patients.

Experienced in Gamma Knife Radiosurgery
Dr. Harry Van Loveren
Neurosurgery
Experienced in Gamma Knife Radiosurgery
Dr. Harry Van Loveren
Neurosurgery

University Medical Service Association Inc

2 Tampa General Cir, 2nd, 
Tampa, FL 
 (9.1 miles away)
813-209-8596
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Harry Van Loveren is a Neurosurgery provider in Tampa, Florida. Dr. Van Loveren is rated as an Advanced provider by MediFind in Gamma Knife Radiosurgery. His top areas of expertise are Pituitary Tumor, Meningioma, Trigeminal Neuralgia, Awake Craniotomy, and Gamma Knife Radiosurgery.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Vogelbaum's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 9 Advanced Conditions
View All 32 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile